SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-129988
Filing Date
2004-08-03
Accepted
2004-08-03 12:16:45
Documents
7
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004. d10q.htm 10-Q 474463
2 TERMINATION AGREEMENT dex10205.htm EX-10.205 10155
3 SECOND AMENDMENT TO LOAN AGREEMENT dex10206.htm EX-10.206 13566
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8815
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8673
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3026
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3008
  Complete submission text file 0001193125-04-129988.txt   524011
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 04947354
SIC: 8731 Services-Commercial Physical & Biological Research